İpek Yönal Hindilerden (Ipek Yonal-Hindilerden)

ResearcherID ORCID

Publication Activity (10 Years)

Years Active: 2020-2021
Publications (10 Years): 2

Top Topics

Ejection Fraction

Prognostic Factors

End Stage Renal Disease

Hodgkin Lymphoma

Top Venues

Molecular biology reports

Journal of chemotherapy (Florence, Italy)

This page only lists publications with an associated author ORCID identifier.

Publications

Bahar Uncu Ulu, Mehmet Sinan Dal, İpek Yönal Hindilerden, Olga Meltem Akay Yanar, Özgür Mehta, Nurhilal Büyükkurt, Fehmi Hindilerden, Ahmet Kursad Gunes, Tuğçe Nur Yiğenoğlu, Başcı Semih, Merih Kızıl Çakar, Didar Yanardag Acik, Serdal Korkmaz, Turgay Ulas, Gülsüm Özet, Burhan Ferhanoğlu, Meliha Nalçacı, Fevzi Altuntaş
Brentuximab vedotin and bendamustine: an effective salvage therapy for relapsed or refractory Hodgkin lymphoma patients. Journal of chemotherapy (Florence, Italy) (2021)
Aynur Daglar-Aday, Ayşegül Başak Akadam-Teker, İpek Yönal Hindilerden, Hasan Dermenci, Ezgi Sahin, Fehmi Hindilerden, Hülya Yılmaz-Aydoğan, Oguz Ozturk, Akif Selim Yavuz
The impact of CYP2D6*4 and GSTP1 Ile105Val polymorphisms on the susceptibility to develop BCR-ABL1 negative myeloproliferative neoplasms. Molecular biology reports 47 (10) (2020)